Discovery of GPR84 Fluorogenic Probes Based on a Novel Antagonist for GPR84 Bioimaging
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Yufeng Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shangha…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Fluorescent Dyes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
GPR84 is a promising therapeutic target and biomarker for a range of diseases. In this study, we reported the discovery of BINOL phosphate (BINOP) derivatives as GPR84 antagonists. By investigating the structure-activity relationship, we identified 15S as a novel GPR84 antagonist. 15S exhibits low nanomolar potency and high selectivity for GPR84, while its enantiomer 15R is less active. Next, we rationally designed and synthesized a series of GPR84 fluorogenic probes by conjugating Nile red and compound 15S. The leading hybrid, probe F8, not only retained GPR84 activity but also exhibited low nonspecific binding and a turn-on fluorescent signal in an apolar environment. F8 enabled visualization and detection of GPR84 in GPR84-overexpressing HEK293 cells and lipopolysaccharide-stimulated neutrophils. Furthermore, we demonstrated that F8 can detect upregulated GPR84 protein levels in mice models of inflammatory bowel disease and acute lung injury. Thus, compound F8 represents a promising tool for studying GPR84 functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, Shandong, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
ORCID-Profile: Linhai Chen, Fajun Nan
Förderung
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Xiao, Y., Chen, J., Li, S., Zhang, Q., Liu, Y., Chen, L., Sun, Y., Gu, M., Xie, X., & Nan, F. (2024). Discovery of GPR84 Fluorogenic Probes Based on a Novel Antagonist for GPR84 Bioimaging. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00359
Vancouver
Xiao Y, Chen J, Li S, Zhang Q, Liu Y, Chen L, et al. Discovery of GPR84 Fluorogenic Probes Based on a Novel Antagonist for GPR84 Bioimaging. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00359
BibTeX
@article{Xiao2024,
author = {Xiao, Yufeng and Chen, Jing and Li, Shaoxian and Zhang, Qing and Liu, Yin and Chen, Linhai and Sun, Yadi and Gu, Min and Xie, Xin and Nan, Fajun},
title = {Discovery of GPR84 Fluorogenic Probes Based on a Novel Antagonist for GPR84 Bioimaging},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00359}
}
EUVIMED